Michael Mastrangelo, MD

Contact Dr. Mastrangelo

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Medical School
Johns Hopkins University School of Medicine - 1964

Residency
Thomas Jefferson University Hospital 1970 - 1971

Fellowship
Thomas Jefferson University Hospital 1969 - 1970

Board Certification
Medical Oncology
Internal Medicine

Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff

University Appointment
Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Melanoma, Skin Cancer

Publications

Most recent Peer-reviewed Publications

1. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
2. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
3. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
4. Masthead
5. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
6. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
7. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2
8. Conjunctival melanoma: Bladder and upper urinary tract metastases
9. The wrath of RAFs: Rogue behavior of B-RAF kinase inhibitors
10. Malignant melanoma presenting as obstructive jaundice secondary to metastasis to the ampulla of vater
11. The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?
12. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
13. High-dose immunoembolization: Survival benefit in patients with hepatic metastases from uveal melanoma
14. Impact of malignant disease on young adults.
15. Foreword
16. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor
17. Malignant melanoma of the gallbladder: A report of two cases and review of the literature
18. In Appreciation: John Williamson Yarbro, MD, PhD
19. Reflecting on the 2001 American Joint Committee on Cancer Staging System for Melanoma
20. Metastatic melanoma causing jejunal intussusception

View All Publications